Difference between revisions of "Team:UofC Calgary/Parts"

Line 271: Line 271:
  
 
                             </div>
 
                             </div>
                             <div class="col-sm-3" style="padding-left:14px; padding-right:14px">  
+
                             <div class="col-sm-3" style="padding-left:7px; padding-right:7px">  
 
                                   <h3 class="human-practices-div-2">BBa_K2008002
 
                                   <h3 class="human-practices-div-2">BBa_K2008002
 
</h3>
 
</h3>
 
  <p class="human-practices-div-2">BBI with N-terminal sec and TD1 tags fused to GFP and under the pVeg promoter for expression in <em>B. subtilis</em></p><ul><li><p class="human-practices-div-2">Sequence-confirmed</p></li><li><p class="human-practices-div-2">Submitted to the registry</p></li><li><p class="human-practices-div-2"><a href="http://parts.igem.org/Part:BBa_K2008002">Registry Link</a></p></li></ul>               
 
  <p class="human-practices-div-2">BBI with N-terminal sec and TD1 tags fused to GFP and under the pVeg promoter for expression in <em>B. subtilis</em></p><ul><li><p class="human-practices-div-2">Sequence-confirmed</p></li><li><p class="human-practices-div-2">Submitted to the registry</p></li><li><p class="human-practices-div-2"><a href="http://parts.igem.org/Part:BBa_K2008002">Registry Link</a></p></li></ul>               
 
                             </div>
 
                             </div>
<div class="col-sm-3" style="padding-left:14px; padding-right:14px">  
+
<div class="col-sm-3" style="padding-left:7px; padding-right:7px">  
 
                                   <h3 class="human-practices-div-2">BBa_K2008003  
 
                                   <h3 class="human-practices-div-2">BBa_K2008003  
 
</h3>
 
</h3>
Line 295: Line 295:
  
 
                             </div>
 
                             </div>
                             <div class="col-sm-3" style="padding-left:14px; padding-right:14px">  
+
                             <div class="col-sm-3" style="padding-left:7px; padding-right:7px">  
 
                                   <h3 class="human-practices-div-2">BBa_K2008006
 
                                   <h3 class="human-practices-div-2">BBa_K2008006
 
   
 
   
Line 301: Line 301:
 
  <p class="human-practices-div-2">Improved version of <i>comK</i> gene with removal of internal restriction sites</p><ul><li><p class="human-practices-div-2">Sequence-confirmed</p></li><li><p class="human-practices-div-2">Submitted to the registry</p></li><li><p class="human-practices-div-2"><a href="http://parts.igem.org/Part:BBa_K2008006">Registry Link</a></p></li></ul>               
 
  <p class="human-practices-div-2">Improved version of <i>comK</i> gene with removal of internal restriction sites</p><ul><li><p class="human-practices-div-2">Sequence-confirmed</p></li><li><p class="human-practices-div-2">Submitted to the registry</p></li><li><p class="human-practices-div-2"><a href="http://parts.igem.org/Part:BBa_K2008006">Registry Link</a></p></li></ul>               
 
                             </div>
 
                             </div>
<div class="col-sm-3" style="padding-left:14px; padding-right:14px">  
+
<div class="col-sm-3" style="padding-left:7px; padding-right:7px">  
 
                                   <h3 class="human-practices-div-2"><font color=#A2310F>♥</font>BBa_K2008007  
 
                                   <h3 class="human-practices-div-2"><font color=#A2310F>♥</font>BBa_K2008007  
 
</h3>
 
</h3>

Revision as of 21:54, 18 October 2016

iGEM Calgary 2016

Parts

The backbone of the U of Calgary project are the composite parts. Our composite parts are an amalgamation of different registry parts which act together to provide a novel function. The composite parts designed for this project are based around the modified Bowman-Birk Protease Inhibitor (mBBI) and the competency-inducing ComK part that was submitted to the registry by the 2014 UofC_Calgary team.


A variety of different parts were used across all of the mBBI composite constructs. We used Pveg, a constitutive E. coli and B. subtilis promoter, and double terminators to book-end internal genes upon chromosomal integration. To improve secretion and transdermal delivery of mBBI from B. subtilis, we added a secretion (sec) tag as well as a transdermal (TD1) tag. The secretion tag is a localization tag for the Sec pathway in B. subtilis (Fu et al., 2007). TD1 is a part previously developed by the USTC_China 2013 iGEM team, and it is designed to allow for the trafficking of peptides across the skin.


The second major composite part was the ComK construct. ComK is a transcription factor and master regulator for competency in B. subtilis. We modified the original ComK sequence, which was first submitted by the 2014 UofC_Calgary team, to remove unwanted restriction sites from within the ComK gene itself. The ComK gene and xylose-inducible promoter were then flanked with sequences homologous to the amyE locus in B. subtilis, a non-essential gene responsible for the degradation of starch. These flanking sequences were added to allow for the integration of a controllable ComK into the B. subtilis genome. The integration of a xylose-inducible ComK allows for the transformation of B. subtilis to be more time-efficient and less resource-intensive.


Our last construct does not fall into either of the two previous categories. The construct is an integration cassette, which is a mix of both the mBBI and Comk constructs. Our cassette contains thrC integration sequences which flank the sec and TD1 tag. However, the mBBI sequence is replaced with the restriction sites for BamHI and XmaI restriction enzymes. Addition of the restriction sites allows for directional cloning of any desired insert, allowing B. subtilis to be used as a platform for future biotherapeutics, creating a portable mini-pharmacy.

Composite Parts

BBa_K2008001

BBI with N-terminal KSCI solubility tag fused to GFP for expression in E. coli

BBa_K2008002

BBI with N-terminal sec and TD1 tags fused to GFP and under the pVeg promoter for expression in B. subtilis

BBa_K2008003

BBI with N-terminal KSCI solubility, sec, and TD1 tags fused to GFP and under the pVeg promoter for expression in B. subtilis

BBa_K2008004

BBI with N-terminal sec and TD1 tags under the pVeg promoter for expression in B. subtilis

BBa_K2008005

BBI with KSCI solubility, sec, and TD1 tags under the pVeg promoter for expression in B. subtilis

  • Sequence-confirmed

  • Characterized

  • Submitted to the registry

  • Registry Link

BBa_K2008006

Improved version of comK gene with removal of internal restriction sites

BBa_K2008007

Improved version of comK with addition of flanking regions of amyE homology

BBa_K2008008

Modular secretion platform containing sec and TD1 tags with flanking regions of thrC homology for chromosomal integration in B. subtilis



References


Fu, L.L., Xu, Z.R., Li, W.F., Shuai, J.B., Lu, P., and Hu, C.X. (2007). Protein secretion pathways in Bacillus subtilis: implication for optimization of heterlogous protein secretion. Biotechnology Advances 25(1): 1-12.

iGEM

iGEM is an international competition promoting synthetic biology as a means to solve social, economic and humanitarian problems around the globe. The iGEM Jamboree is held in Boston annually. In 2016, over 300 teams are competing against each other.

Latest Entries

Fully Trained!

Our entire team received a full BioSafety education from the University of Calgary! This entailed going to classes to prepare for a final quiz that tested our ability to be safe in the lab. Several of our members also had radiation training and clearance to ensure that work done with radiation was safe!

Read More

Latest Pictures

View More

Find us

Located in Calgary, Alberta, Canada.

  • University of Calgary
  • igem.calgary@gmail.com
\